Anti-Tumor Activity of Non-Nucleosidic Reverse Transcriptase Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
737-747
Author(s):
Matteo Landriscina, Corrado Spadafora, Mauro Cignarelli and Carlo Barone
Poly(ADP-Ribose) Polymerase Inhibitors: New Pharmacological Functions and Potential Clinical Implications
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
933-962
Author(s):
C. Alarcon de la Lastra, I. Villegas and S. Sanchez-Fidalgo
Bortezomib: Proteasome Inhibition as a Novel Mechanism of Cancer Therapy-Implications for Hematological Malignancies
Journal:
Letters in Drug Design & Discovery
Volume:
4
Page:
82-86
Author(s):
Joesph Mikhael and Hong Chang
Immunotherapeutic Approaches in MS: Update on Pathophysiology and Emerging Agents or Strategies 2006
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
7
Page:
35-63
Author(s):
C. Kleinschnitz, S. G. Meuth, B. C. Kieseier and H. Wiendl
CD26/Dipeptidyl Peptidase IV as a Novel Therapeutic Target for Cancer and Immune Disorders
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
7
Page:
253-273
Author(s):
Michael A. Thompson, Kei Ohnuma, Masako Abe, Chikao Morimoto and Nam H. Dang
Chemogenomics of Sensitivity and Resistance to Anticancer Drugs
Journal:
Current Pharmacogenomics
Volume:
5
Page:
11-19
Author(s):
Zunyan Dai, Wolfgang Sadee and Paul Blower
Radiolabeled Peptides and Proteins in Cancer Therapy
Journal:
Protein & Peptide Letters
Volume:
14
Page:
273-279
Author(s):
Carmen Wangler, Inga Buchmann, Michael Eisenhut, Uwe Haberkorn and Walter Mier
Subject Index To Volume 7
Journal:
Current Pharmaceutical Biotechnology
Volume:
8
Page:
ix-ix
Author(s):
Bentham Science Publishers
Editorial [ Hot Topic: Highlights on Important Signaling Pathways as Drug Targets in Hematological Malignancies (Guest Editors: H. Serve and H.C. Hasselbalch) ]
Journal:
Current Drug Targets
Volume:
8
Page:
203-203
Author(s):
Hubert Serve and Hans Carl Hasselbalch
Targeting the RAS Signaling Pathway in Malignant Hematologic Diseases
Journal:
Current Drug Targets
Volume:
8
Page:
217-235
Author(s):
M. A. Morgan, A. Ganser and C. W. M. Reuter